Influence of Angiotensin Converting Enzyme Insertion/Deletion Polymorphism on Long-term Total Graft Occlusion after Coronary Artery Bypass Surgery


  • Sennur Unal Dayi
  • Zeynep Tartan
  • Sait Terzi
  • Hulya Kasikcioglu
  • Hüseyin Uyarel
  • Gokcen Orhan
  • Ahmet Taha Alper
  • Figen Ciloglu
  • Nese Cam



Background: The renin-angiotensin system has a very important role in coronary thrombosis and restenosis. Plasma angiotensin converting enzyme (ACE) activity is associated with an insertion/deletion polymorphism in the gene coding for ACE. It is known that there is a strong correlation between ACE DD and atherosclerosis. However, little has been documented about its role in venous graft failure. The objective of this study was to investigate the relationships among the ACE gen polymorphism and long-term vein graft occlusion.

Methods: The study population consisted of 87 consecutive white patients with symptomatic coronary artery disease in the previous month, who had had aorto-coronary bypass surgery (ACBS) more than 5 years back and who underwent coronary angiography for diagnostic purposes. On the same day as angiography, 10 mL whole blood was taken for ACE gene insertion/deletion (I/D) polymorphism.

Results: Mean age of the patients was 64.4 ± 8.6 years, and 71 (82%) of the patients were men. The average ACBS time was 7.9 ± 1.9 years. The ACE genotype was II in 15 patients (17.2%), ID in 47 patients (54.0%), and DD in 25 patients (28.7%). Thus, D allele frequency was .82. There was no significant difference between the cases with regard to age, body mass index, blood pressure status, plasma glucose level, plasma lipid profile, smoking status, average of ACBS time or family history of coronary heart disease. In ACE II group 5 patients had total venous graft occlusion, in ACE ID group 27 patients had total occlusion and in ACE DD group 20 patients had at least one graft total occlusion. The frequency of the venous graft occlusion about total venous grafts is 36% in the ACE II group, 49% in the ACE ID group, and 80% in the ACE DD group (P = .01). Conclusion: The ACE I/D gene polymorphism is associated with long-term survival of venous conduit. The ACE DD genotype or D allele influences the angiographic outcome of patients post-ACBS. These data suggest that routine determination of the ACE genotype may help identify patients who are at higher risk of venous graft failure after ACBS.


Campeau L, Enjalbert M, Lesperance J, et al. 1984. The relation of risk factors to the development of atherosclerosis in saphenous vein bypass grafts and the progression of disease in the native circulation: a study 10 years after aortocoronary bypass surgery. N Eng J Med 311:1329-32.nFarber HW, Center DM, Rounds S, et al. 1990. Components of the angiotensin system cause release of a neutrophil chemoattractant from cultured bovine and human endothelial cells. Eur Heart J 11:Suppl 100-7.nO'Donohoe MK, Davies MG, Radic ZS, et al. 1994. Increased concentrations of angiotensin-converting enzyme in the intimal hyperplasia of experimental vein grafts. J Cardiovasc Pharmacol 23:594-601.nSamani NJ, Thompson JR, O'Toole L, et al. 1996. A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation 94:708-12.nAmant C, Bauters C, Bodart JC, et al. 1997. D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting. Circulation 96:56-60.nBonithon-Kopp C, Ducimetiere P, Touboul PJ, et al. 1994. Plasma angiotensin-converting enzyme activity and carotid wall thickening. Circulation 89:952-4.nBourassa MG. 1991. Fate of venous grafts: the past, the present, and the future. J Am Coll Cardiol 17:1081-3.nCambien F, Alhenc-Gelas F, Herbeth B, et al. 1988. Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy Study. Am J Hum Genet 43:774-80.nCambien F, Poirier O, Lecerf L, et al. 1992. Deletion polymorphism in the gene for angiotensin converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641-4.nKoch W, Kastrati A, Mehilli J, et al. 2000. Insertion/Deletion of the angiotensin I-converting enzyme gene is not associated with restenosis after coronary stent placement. Circulation 102:197-202.nDelange J, Cambier B, Langlois M, et al. 1997. Haptoglobin polymorphism, a genetic risk factor in coronary artery bypass surgery. Atherosclerosis 132:215-9.nEhlers MR, Riordan JF. 1989. Angiotensin converting enzyme: new concepts concerning its biological role. Biochemistery 28:5311-8.nEvans AE, Poirier O, Kee F, et al. 1994. Polymorphisms of the angiotensin-converting-enzyme gene in subjects who die from coronary heart disease. Q J Med 87:211-4.nRuiz J, Blanche H, Cohen N, et al. 1994. Insertion/deletion polymorphism of the angiotensin converting enzyme gene is strongly associated with coronary heart disease in non-insulin dependent diabetes mellitus. Proc Natl Acad Sci USA 91:3662-5.nMorrow DA, Gersh BJ, Braunwald E. 2005. Chronic coronary artery disease. In: Braunwald E, ed. Heart disease. A textbook of cardiovascular medicine. 7th ed. Philadelphia, PA: WB Saunders; p. 1311-7.nAgerholm-Larsen B, Nordestgaard BG, Steffensen R, et al. 1997. ACE gene polymorphism: ischemic heart disease and longevity in 10150 individuals. A case-referent and retrospective cohort study based on the Copenhagen City Heart Study. Circulation 95:2358-67.nVolzke H, Engel J, Kleine V, et al. 2002. Angiotensin I-converting enzyme insertion/deletion polymorphism and cardiac mortality and morbidity after coronary artery bypass graft surgery. Chest 122:31-6.nFinta KM, Fischer MJ, Lee L, et al. 1993. Ramipril prevents impaired endothelium-dependent relaxation in arteries from rabbits fed on atherogenic diet. Atherosclerosis 100:149-56.nFitzgibbon GM, Kafka HP, Leach AJ, et al. 1996. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5065 grafts related to survival and reoperation in 1388 patients during 25 years. J Am Coll Cardiol 28:616-26.nGardemann A, Weiss T, Schwartz O, et al. 1995. Gene polymorphism but not catalytic activity of angiotensin I-converting enzyme is associated with coronary artery disease and myocardial infarction in low-risk patients. Circulation 92:2796-9.nRibichini F, Steffenino G, Dellavalle A, et al. 1998. Plasma activity and insertion/deletion polymorphism of angiotensin I converting enzyme: a major risk factor and a marker of risk for coronary stent restenosis. Circulation 97:147-54.nRigat B, Hubert C, Alhenc-Gelas F, et al. 1990. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-6.nMattu RK, Needham EW, Galton DJ, et al. A DNA variant at the angiotensin-converting enzyme locus associates with coronary artery disease in the Caerphilly Heart Study. Circulation 91:270-4.nMotwani JG, Topol EJ. 1998. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 97:916-31.nOike Y, Hata A, Ogata Y, et al. 1995. Angiotensin converting enzyme as a genetic risk factor for coronary artery spasm. Implication in the pathogenesis of myocardial infarction. J Clin Invest 96:2975-9.n



How to Cite

Dayi, S. U., Tartan, Z., Terzi, S., Kasikcioglu, H., Uyarel, H., Orhan, G., Alper, A. T., Ciloglu, F., & Cam, N. (2005). Influence of Angiotensin Converting Enzyme Insertion/Deletion Polymorphism on Long-term Total Graft Occlusion after Coronary Artery Bypass Surgery. The Heart Surgery Forum, 8(5), E373-E377.




Most read articles by the same author(s)